⌘K

Login Start Free

Home/Filings/4/0001415889-23-004275

4//SEC Filing

Sawaf Aziz 4

Accession 0001415889-23-004275

CIK 0001583107other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:38 PM ET

Size

4.5 KB

Accession

0001415889-23-004275

Insider Transaction Report

Form 4

Period: 2023-03-01

Theravance Biopharma, Inc.TBPH

SVP & CHIEF FINANCIAL OFFICER

Transactions

Award
Ordinary Shares
2023-03-01+80,000→ 277,717 total

Documents

1 file

4
form4-03042023_010338.xmlPrimary

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1

filerCIK 0001961289

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 8:38 PM ET
Size: 4.5 KB

View on SEC.gov